Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Head-to-head comparison of Selank and Semax — mechanism, dosing, side effects, legal status, and pricing.
Selank is a synthetic analog of the immunomodulatory peptide tuftsin, developed in Russia for its anxiolytic and nootropic properties. It is studied for its ability to reduce anxiety without sedation and enhance cognitive performance.
Semax is a synthetic heptapeptide analog of ACTH(4-10) developed in Russia as a nootropic and neuroprotective agent. It is studied for cognitive enhancement, stroke recovery, and neurodegenerative conditions.
Selank
Semax
Category
Legal Status
Mechanism
Dose Range
Route
Frequency
Dosing Notes
Side Effects
Contraindications
Approved in Russia as a prescription anxiolytic nasal spray. Clinical studies show reductions in generalized anxiety comparable to benzodiazepines but without sedation or cognitive impairment. It also demonstrates immunomodulatory and nootropic effects in preclinical models.
Approved in Russia and Ukraine for stroke recovery, cognitive disorders, and peptic ulcers. Preclinical studies demonstrate neuroprotection against ischemic damage and improved memory formation. Its nootropic effects are well-documented in Russian medical literature.
Key references
Selank and Semax are both in the Cognitive category and may have overlapping mechanisms. Researchers should review both profiles carefully, understand the mechanisms of action, and monitor the relevant biomarkers when combining compounds in the same class. As always, consult a licensed healthcare provider before making any decisions about combining research compounds.
This platform provides informational tools only, not medical advice. This comparison is for educational purposes only. Consult a licensed provider.
Disclosed Labs